Hillsdale Investment Management Inc. Invests $76,000 in LifeVantage Co. (NASDAQ:LFVN)

Hillsdale Investment Management Inc. bought a new position in shares of LifeVantage Co. (NASDAQ:LFVN) in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor bought 12,620 shares of the company’s stock, valued at approximately $76,000. Hillsdale Investment Management Inc. owned 0.10% of LifeVantage at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. Ritholtz Wealth Management grew its holdings in shares of LifeVantage by 23.5% during the fourth quarter. Ritholtz Wealth Management now owns 25,027 shares of the company’s stock worth $150,000 after buying an additional 4,756 shares in the last quarter. Empowered Funds LLC increased its holdings in LifeVantage by 8.1% in the 1st quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock valued at $461,000 after purchasing an additional 5,742 shares during the last quarter. Acadian Asset Management LLC grew its stake in shares of LifeVantage by 2.8% in the first quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after buying an additional 6,121 shares in the last quarter. Finally, Vanguard Group Inc. raised its holdings in shares of LifeVantage by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock valued at $2,874,000 after buying an additional 12,809 shares during the period. 35.32% of the stock is currently owned by institutional investors and hedge funds.

LifeVantage Stock Performance

Shares of LFVN traded down $0.14 during mid-day trading on Monday, hitting $6.47. 42,584 shares of the company’s stock were exchanged, compared to its average volume of 39,326. The company has a market cap of $82.17 million, a price-to-earnings ratio of 23.11 and a beta of 0.81. LifeVantage Co. has a fifty-two week low of $4.20 and a fifty-two week high of $8.69. The stock’s 50-day moving average is $6.88 and its 200-day moving average is $6.52.

LifeVantage (NASDAQ:LFVN) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.21 earnings per share for the quarter. LifeVantage had a return on equity of 27.02% and a net margin of 1.75%. The company had revenue of $48.25 million for the quarter.

LifeVantage Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.